Dehydroepiandrosterone (DHEA) PCD Pharma Franchise Company
Cafoli Lifecare is a trusted WHO-GMP certified Dehydroepiandrosterone (DHEA) PCD pharma franchise company, offering a focused range of 5 quality Dehydroepiandrosterone formulations to franchise partners across India. Every batch is manufactured in WHO-GMP compliant facilities and supplied with district-wise monopoly rights so distributors can build a protected territory.
What is Dehydroepiandrosterone?
Dehydroepiandrosterone (DHEA) is an endogenous steroid hormone produced mainly by the adrenal glands, and it acts as a precursor from which the body forms androgens and estrogens such as testosterone and estradiol. It is used only under medical supervision in defined hormonal indications and is a prescription-sensitive molecule. Detailed chemical data is available on PubChem.
Available Dehydroepiandrosterone Formulations
Cafoli Lifecare supplies Dehydroepiandrosterone across 5 formulations in the following forms: Softgel and Tablets. Each pack is produced under strict quality control and is available for monopoly-based distribution. Confirmed MRP for each pack is shared on request at the time of order.
Therapeutic Applications of Dehydroepiandrosterone
Under specialist supervision, Dehydroepiandrosterone is considered in hormone-related indications such as adrenal insufficiency and selected androgen or estrogen deficiency states. Because it is a hormonal molecule, it is prescribed and monitored by endocrinologists, gynaecologists and physicians, and must only be dispensed against a valid prescription. Cafoli does not support any off-label or unsupervised use.
Why Dehydroepiandrosterone is a High-Potential Molecule for Distributors
Hormonal and specialty molecules like Dehydroepiandrosterone attract steady, prescription-driven demand from endocrinology and gynaecology practices where alternatives are limited. Because it is a niche product, distributors face less price-based competition and can build durable relationships with specialist prescribers, making a DHEA franchise a differentiated addition to a PCD portfolio.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved products, and complete promotional inputs to help partners grow. With a network of more than 1000 franchise partners across India, Cafoli provides reliable supply, transparent pricing and dedicated support for its Dehydroepiandrosterone range.
References
- PubChem - Dehydroepiandrosterone
- PubMed - Dehydroepiandrosterone research
Our formulations of Dehydroepiandrosterone find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: